Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
BJOG : an International Journal of Obstetrics and Gynaecology|August 22, 2008
Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from a national case-control study--Part 2H E Seaman, K D Ballard, J T Wright, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 22, 2008
Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study--Part 1K D Ballard, H E Seaman, C S de Vries, et al.
BMJ Case Reports|August 10, 2017
GSK2586184, a JAK1 selective inhibitor, in two patients with ulcerative colitisLeonie C S De Vries, Valerie J Ludbrook, Kirsty J Hicks, et al.
Journal of Crohn'S & Colitis|February 4, 2017
The Future of Janus Kinase Inhibitors in Inflammatory Bowel DiseaseL C S De Vries, M E Wildenberg, W J De Jonge, et al.
British Journal of Clinical Pharmacology|March 22, 2001
Effect of diuretics on fetal growth: A drug effect or confounding by indication? Pooled Danish and Scottish cohort dataC Olesen, C S de Vries, N Thrane, et al.
Pharmacy World & Science : PWS|June 25, 1999
Prescription data as a tool in pharmacotherapy audit (I). General considerationsC S de Vries, T F Tromp, W Blijleven, et al.
Drug Safety|September 16, 1999
Changing prescribing in the light of tolerability concerns: how is this best achieved?C S de Vries, C A Duggan, T F Tromp, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Auditing GPs' prescribing habits: cardiovascular prescribing frequently continues medication initiated by specialistsC S de Vries, N M van Diepen, T F Tromp, et al.
The International Journal of Risk & Safety in Medicine|March 21, 2013
Registration of drug use in a birth defect monitoring system: a priority worthy of emphasis!C S de Vries, H E de Walle, M C Cornel, et al.
Pageof 4